Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

adaptiQ™ system for ready-to-use pharmaceutical vials launched by SCHOTT

SCHOTT introduced its adaptiQ™ system for ready-to-use pharmaceutical vials, which allows for more flexible manufacturing concepts and more efficient filling. Designed in close collaboration with filling line manufacturers to meet the pharmaceutical industry’s process requirements, SCHOTT adaptiQ consists of a patented nest that securely holds as many as 100 clean and sterile vials in an industry standard tub.

12 Nov 2013

New diagnostic products from Avantor™ Performance Materials featured at MEDICA 2013

Avantor™ Performance Materials will display its capabilities as a trusted collaborator and provider of high-quality diagnostic solutions at MEDICA 2013, November 20-23 at the Dusseldorf Fairgrounds in Germany.

12 Nov 2013

Promethera Biosciences completes patient enrolment for first clinical trial of HepaStem

Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today the completion of patient enrolment for its first clinical trial.

12 Nov 2013

BioGaia plans to invest in first phase of project aimed at developing drug for NEC

The board of BioGaia has decided to invest in the first phase of a long-term project aimed at developing a drug with rigorous hygiene, analysis and documentation requirements, to treat the highly fatal disease Necrotising Enterocolitis, which affects premature infants.

12 Nov 2013

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.

11 Nov 2013

ERBA Diagnostics’ net revenues increase 83% to $6,941,000 in third quarter 2013

ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, reported its financial results for the three and nine months ended September 30, 2013.

11 Nov 2013

FDA proposes rule to speed dissemination of new safety information about generic drugs

A proposed U.S. Food and Drug Administration rule would speed the dissemination of new safety information about generic drugs to health professionals and patients by allowing generic drug makers to use the same process as brand drug manufacturers to update safety information in the product labeling.

11 Nov 2013

UAB surgical team performs first surgery using VIPAAR and Google Glass

A University of Alabama at Birmingham surgical team has performed the first surgery using a virtual augmented reality technology called VIPAAR in conjunction with Google Glass, a wearable computer with an optical head-mounted display. The combination of the two technologies could be an important step toward the development of useful, practical telemedicine.

11 Nov 2013

ChinaSoft inks agreement with CITIC 21CN on Pharmaceutical Information Sharing Program

ChinaSoft International Limited, announced that it has signed a strategic agreement with CITIC 21CN Company Limited on the Pharmaceutical Information Sharing Program.

11 Nov 2013

Genovate, ScinoPharm to jointly develop new-generation oral Hepatitis B drug Livepro

Genovate Biotechnology Co. Ltd. and ScinoPharm Taiwan Ltd. announced today that they have jointly developed the highly potent oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of Hepatitis B. It is expected to be commercially available by the end of the year in Taiwan, accounting for more than NT$2 billion (US$70 million) worth of market opportunity.

11 Nov 2013

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

The U.S. Food and Drug Administration today approved the first generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease in adults and adolescents (ages 12 and up).

10 Nov 2013

Olympus hosts fourth annual neuroimaging symposium on functional brain imaging with cellular resolution

Olympus is hosting its fourth annual neuroimaging symposium in conjunction with the 2013 meeting of the Society for Neuroscience (SfN) on Monday, November 11 in San Diego. The Olympus Neuroimaging Symposium will be held near the Convention Center at the San Diego Marriott Marquis and Marina, San Diego Ballroom – Salon A, beginning at 6:30pm. The symposium and reception are open to all media and SfN registered attendees.

From Evident Corporation - Life Sciences 8 Nov 2013

Drug formulation services for highly potent active pharmaceutical ingredients provided by Evonik

Evonik Industries has broadened its capabilities in finished drug product formulation and clinical supply manufacturing and can now handle drug products containing highly potent active pharmaceutical ingredients (HPAPIs) in Darmstadt, Germany, and Birmingham, Alabama/USA. Investments in high containment facilities and upgrades in the laboratory and GMP areas in Birmingham enable Evonik to handle HPAPIs with occupational exposure limits (OEL) as low as 0.1μg/m3 and in Darmstadt as low as 1 μg/m3. Starting 2014, OEL as low as 0.1μg/m3 will also be possible in Darmstadt.

8 Nov 2013

GSI Group generates revenue of $85.5 million during third quarter 2013

GSI Group Inc., a global leader and supplier of precision photonics and motion control components and subsystems to the medical, industrial, electronics and scientific markets, today reported financial results for the third quarter of 2013.

6 Nov 2013

Furiex reports financial and operating results for third quarter 2013

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today reported its financial and operating results for the quarter ended September 30, 2013.

6 Nov 2013

New research may lead to novel approaches for preventing tissue injury during cryopreservation

Developing an efficient way to freeze and store living tissues could transform many aspects of medical care and research, but ice crystallization often occurs within cells during such cryopreservation procedures, leading to cell death.

6 Nov 2013

Bioniche Life Sciences announces financial results for first quarter of Fiscal 2014

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of Fiscal 2014 (ended September 30, 2013).

6 Nov 2013

Life Technologies revenue for third quarter increases 3% to $936

Life Technologies Corporation (NASDAQ: LIFE) today announced results for its third quarter ended September 30, 2013. Revenue for the third quarter was $936 million, an increase of 3 percent over the $911 million reported for the third quarter of 2012.

5 Nov 2013

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Reviva Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the discovery and development of new, safer and highly effective therapies for chronic indications, announced today the successful completion of an End-of-Phase 2 meeting with the Food and Drug Administration for its lead, new investigational antipsychotic drug, RP5063.

5 Nov 2013

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

Zevacor Molecular, an independently owned healthcare firm that manufactures and distributes PET and SPECT radiopharmaceuticals, has purchased the first 70 MeV Cyclotron dedicated to medical use in the United States from Ion Beam Applications, S.A.

5 Nov 2013

Manufacturing News and Research

Further Reading

adaptiQ™ system for ready-to-use pharmaceutical vials launched by SCHOTT

New diagnostic products from Avantor™ Performance Materials featured at MEDICA 2013

Promethera Biosciences completes patient enrolment for first clinical trial of HepaStem

BioGaia plans to invest in first phase of project aimed at developing drug for NEC

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

ERBA Diagnostics’ net revenues increase 83% to $6,941,000 in third quarter 2013

FDA proposes rule to speed dissemination of new safety information about generic drugs

UAB surgical team performs first surgery using VIPAAR and Google Glass

ChinaSoft inks agreement with CITIC 21CN on Pharmaceutical Information Sharing Program

Genovate, ScinoPharm to jointly develop new-generation oral Hepatitis B drug Livepro

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

Olympus hosts fourth annual neuroimaging symposium on functional brain imaging with cellular resolution

Drug formulation services for highly potent active pharmaceutical ingredients provided by Evonik

GSI Group generates revenue of $85.5 million during third quarter 2013

Furiex reports financial and operating results for third quarter 2013

New research may lead to novel approaches for preventing tissue injury during cryopreservation

Bioniche Life Sciences announces financial results for first quarter of Fiscal 2014

Life Technologies revenue for third quarter increases 3% to $936

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News